Ozempic medication

Ozempic is a major brand in the pharmaceutical industry used for the treatment of type 2 diabetes and, more recently, for chronic weight management. The medication was developed through the innovation of Novo Nordisk, a company with a long history of expertise in insulin and diabetes care reaching back to the early 20th century.

While the brand has its original roots in Denmark, the distribution and manufacturing are global. Production occurs in specialized facilities in Kalundborg, Denmark, as well as significant manufacturing hubs in Clayton, North Carolina (USA) and Chartres, France, to meet high international demand. Ownership remains stable under the founding entity, which manages the brand globally through various regional subsidiaries.